1 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 140 of 320 | 740 prescriptions Less than 1% of all prescriptions | 600 | 220 patients 20% of all patients | < 11 | |
2 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 60 of 180 | 550 prescriptions Less than 1% of all prescriptions | 330 | 140 patients 13% of all patients | < 11 | |
3 PREDNISONE | 120 of 330 | 700 prescriptions Less than 1% of all prescriptions | 550 | 300 patients 27% of all patients | < 11 | |
4 AZITHROMYCIN | 40 of 250 | 490 prescriptions Less than 1% of all prescriptions | | 130 patients 12% of all patients | < 11 | A |
5 VENTOLIN HFA (ALBUTEROL SULFATE) | 100 of 310 | 710 prescriptions Less than 1% of all prescriptions | 410 | 220 patients 20% of all patients | < 11 | |
6 SPIRIVA (TIOTROPIUM BROMIDE) | 190 of 300 | 410 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 MONTELUKAST SODIUM | 140 of 260 | 290 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 110 of 240 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 PROAIR HFA (ALBUTEROL SULFATE) | 140 of 290 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 ZEMAIRA (ALPHA-1-PROTEINASE INHIBITOR) | 10 of 20 | 260 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
11 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 220 of 310 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 160 of 200 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
13 ESBRIET (PIRFENIDONE) | 60 of 100 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
14 DALIRESP (ROFLUMILAST) | 80 of 80 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
15 OFEV (NINTEDANIB ESYLATE) | 70 of 80 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
16 LEVOFLOXACIN | 30 of 60 | 170 prescriptions Less than 1% of all prescriptions | | 120 patients 11% of all patients | < 11 | A |